Researchers at the University of Pennsylvania have launched Observer, the first multimodal medical dataset to capture ...
NetraMark Holdings Inc. (the “Company” or “NetraMark”) (CSE: AIAI) (OTCQB: AINMF) (Frankfurt: PF0), a premier artificial intelligence (AI) company transforming clinical trials with AI-powered ...
In mCRPC patients with androgen receptor (AR) mutations, treatment with MRT-2359 in combination with enzalutamide led to a 100% PSA response rate (4 of 4 patients) and a 100% disease control rate, ...
Data rules CIOs won’t leave behind in 2026 guide AI governance and data security strategies at University Hospitals and Corewell Health.
The FDA has qualified AI-Based Histologic Measurement of MASH, or AIM-MASH AI Assist — the first AI drug development tool — ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback